For patients who suffer from acute and chronic wounds, a novel device has been developed – the dermaPACE, by Sanuwave. The mechanism of action is based on shockwave technology, which has been used for nearly 30 years in orthopedic treatments and lithotripsy procedures (destruction of kidney stones). These early devices also provided evidence that there was an effect on wound healing. Pulsed Acoustic Cellular Expression (PACE) Technology was developed based on this evidence, and the dermaPACE device is the first to utilize PACE specific proprietary protocols for wound treatment. DermaPACE is CE marked for the application of pulsed acoustic waves on acute and chronic defects of the skin and subcutaneous soft tissues, to treat post-operative wound healing defects, post-traumatic wounds, deep-partial thickness burns, decubitus ulcers, diabetic ulcers, arterial ulcers and venous ulcers. To learn more, see video: